Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-20

Clinical Trial Update: Aspirin AM or PM: Effect on Circadian Rhythm of Platelet Reactivity [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether taking aspirin in the morning or evening influences the circadian rhythm of platelet reactivity; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Leiden University Medical Center | Conditions: Aspirin, Circadian Rhythm | Phase 4 | Status: COMPLETED